Mizuho Medy Co (TSE:4595) Total Stockholders Equity: 円18,332 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4595 Mizuho Medy Co Ltd TSE:4595
82 GF Score
Price 円1,710.00
GF Value 円1,530.68
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Mizuho Medy Co Total Stockholders Equity?

Mizuho Medy Co TSE:4595 +1.18% 82 Total Stockholders Equity is 円18,332 Mil as of Jun. 2026. GuruFocus rates TSE:4595 with a GF Score™ of 82/100 and a GF Value™ of 円1,530.68 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Mizuho Medy Co's Total Stockholders Equity for the quarter that ended in Jun. 2026 was 円18,332 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Mizuho Medy Co's Book Value per Share for the quarter that ended in Jun. 2026 was 円962.36. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Mizuho Medy Co's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.00.

Mizuho Medy Co  (TSE:4595) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Mizuho Medy Co's Book Value per Share for the quarter that ended in Jun. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(18332-0)/19.049
=962.36

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Mizuho Medy Co's Debt-to-Equity for the quarter that ended in Jun. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 18332
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mizuho Medy Co Total Stockholders Equity Related Terms

Mizuho Medy Co Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Mizuho Medy Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mizuho Medy Co Total Stockholders Equity Chart

Mizuho Medy Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,028.64 14,282.70 15,674.00 17,352.00 18,683.00

Mizuho Medy Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17,230.00 16,846.00 18,683.00 18,332.00 18,332.00
TSE:4595
82GF Score
Mizuho Medy Co Ltd TSE:4595
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of 円18,332 Mil mean?
Mizuho Medy Co (TSE:4595) has a Total Stockholders Equity of 円18,332 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Mizuho Medy Co and its competitors.
Is Mizuho Medy Co's Total Stockholders Equity too high?
Mizuho Medy Co's current Total Stockholders Equity is 円18,332 Mil. Overall, Mizuho Medy Co has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mizuho Medy Co's Total Stockholders Equity compare to ZTS?
Mizuho Medy Co's Total Stockholders Equity of 円18,332 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Drug Manufacturers company?
A good Total Stockholders Equity depends on the Drug Manufacturers industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Mizuho Medy Co and its competitors. Mizuho Medy Co's current Total Stockholders Equity is 円18,332 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mizuho Medy Co stock overvalued right now?
Based on GuruFocus' analysis, Mizuho Medy Co (TSE:4595) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,530.68, compared to a current price of 円1,710.00 — trading 11.7% above its estimated fair value. The current Total Stockholders Equity is 円18,332 Mil. Mizuho Medy Co's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Mizuho Medy Co (TSE:4595), the current Total Stockholders Equity is 円18,332 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mizuho Medy Co (TSE:4595) Overvalued in 2026?

Based on GuruFocus' analysis, Mizuho Medy Co stock appears to be overvalued. The current stock price of 円1,710.00 is trading 11.7% above its estimated GF Value™ of 円1,530.68. GuruFocus considers Mizuho Medy Co to be Modestly Overvalued.

Key valuation signals for TSE:4595:

  • Total Stockholders Equity: 円18,332 Mil
  • GF Value™: 円1,530.68 vs. price of 円1,710.00 (11.7% above fair value)
  • GF Score™: 82/100 with 3 warning signs

No single metric tells the full story. See the TSE:4595 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mizuho Medy Co Business Description

Address 5-4 Fujinoki-machi, Saga Prefecture, Tosu, JPN, 841-0048
Mizuho Medy Co Ltd engages in research and development, manufacture, and distribution of in-vitro diagnostic products. The company provides immuno assay test products, such as influenza virus kits; Infectious diseases test kits; fecal occult blood test kits for detection of human hemoglobin and human transferrin in feces; and biochemical liquid stable reagents for professionals. It also offers HCG (midstream test), including a digital p-check test for OTC. It also offers fruit tree virus test drugs to agricultural testing places.
82GF Score

Get the complete analysis for TSE:4595

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,710.00
Price
円1,530.68
GF Value